Table 4.

Differences between the groups regarding access to clinical trials and cultural specific information

	NM	FGM	SGM/TGM	p-value
Offered a clinical trail	216 (50.7%)	29 (28.4%)	34 (56.7%)	< 0.05
Participated in a clinical trail	144 (33.5%)	16 (15.7%)	28 (47.5%)	< 0.05
Offered alternative therapies	162 (39.0%)	37 (37.4%)	27 (48.2%)	0.37
Participated in follow-up care	372 (91.0%)	91 (89.2%)	53 (94.6%)	0.25
Contacted a support group	79 (18.5%)	11 (10.8%)	13 (21.7%)	0.12
Aware of information materials in their preferred language	247 (60.8%)	19 (18.6%)	37 (69.8%)	< 0.05